BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation

Clinical trial NCT05959252 · RECRUITING

Trial details

NCT number: NCT05959252
Sponsor: Sydney Local Health District
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extracorporeal Membrane Oxygenation Complication

Start date: 2024-05-01
Primary completion: 2026-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.